USPTO Affirms Gevo's Request for Reexamination of Butamax Patent

Loading...
Loading...
Gevo, Inc.
GEVO
announced today that the U.S. Patent Office and Trademark (USPTO) has denied a petition by ButamaxTM Advanced Biofuels, LLC (Butamax) which would have vacated the order granting Gevo's reexamination request of Butamax's U.S. Patent No. 7,851,188. In so doing, the USPTO simultaneously affirmed its original decision that all claims challenged by Gevo in the '188 patent remain rejected as unpatentable.
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...